Aurobindo Pharma Share Price Target 2022, 2023, 2024, 2025, 2030

Aurobindo Pharma Share Price Target 2022, 2023, 2024, 2025, 2030:- Aurobindo Pharma is engaged in the manufacturing of pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations such as astemizole, domperidone and omeprazole; anti-infectives, oral and sterile antibiotics, pain management and osteoporosis segments.

Here in this article we try to analyze everything that can happen with Aurobindo Pharma shares.

Aurobindo Pharma Share Price Target 2022

Aurobindo Pharma started operations in 1988-89 with a single Semi-Synthetic Penicillin (SSP) manufacturing unit in Pondicherry. In addition to being the market leader in semi-synthetic penicillin, it has presence in key therapeutic segments such as Neurosciences (CNS), Cardiovascular (CVS), Antiretroviral, Antidiabetic, Gastroenterology and Antibiotics. With cost-effective manufacturing capabilities and several loyal customers, the company has also entered the high-margin specialty generics segment.

Aurobindo Pharma stock price target will be available by the end of financial year 2022. Aurobindo Pharma’s initial price will be around Rs 630. And Aurobindo Pharma’s second target will be Rs 650.

YearAurobindo Pharma Share Price Target 2022
First Target 2022Rs 630
Second Target 2022Rs 650

Also read:- Unitech Share Price Target 2022, 2023, 2024, 2025, 2030

Aurobindo Pharma Share Price Target 2023

Aurobindo has evolved into a knowledge based company manufacturing active pharmaceutical ingredients and formulation products. It focuses on research and development and has a multi-product portfolio with manufacturing facilities in several countries. The formulation business is systematically organized with a divisional structure and has a team focused on key international markets. The company’s API / intermediates and formulation units are designed to meet the requirements of both advanced and emerging market opportunities.

Aurobindo Pharma stock price target by the end of 2023. The target value of Aurobindo Pharma’s first shares for the financial year 2023 is estimated at Rs 750. And the second indicative price of Aurobindo Pharma could offer around Rs 780.

YearAurobindo Pharma Share Price Target 2023
First Target 2022Rs 750
Second Target 2022Rs 780

Also read:- Tinplate Share Price Target 2022, 2023, 2024, 2025, 2030

Aurobindo Pharma Share Price Target 2024

A well-integrated pharmaceutical company, it is among the top 2 pharmaceutical companies in India in terms of consolidated revenue. Aurobindo exports to many countries around the world, with around 90% of revenue coming from international operations. Its customers include premium multinational companies. With many devices approved by leading regulatory agencies such as USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada, WHO and Brazil ANVISA, Aurobindo utilizes in-house R&D for rapid patent filing, Drug Master Files (DMF), Abbreviated New Drug Applications (ANDAs) and formulation dossiers worldwide. It is among the largest DMF and ANDA processors in India.

At this moment we try to predict the price of two Aurobindo  that will be available in 2024. The first target price of Aurobindo Pharmais Rs 900. And Aurobindo Pharma’s second price target could cross Rs 930.

YearAurobindo Pharma Share Price Target 2024
First Target 2024Rs 900
Second Target 2024Rs 930

Also read:- Rallis India Share Price Target 2022, 2023, 2024, 2025, 2030

Aurobindo Pharma Share Price Target 2025

Aurobindo Pharma continues to be one of the fastest growing active pharmaceutical ingredient (API) companies in the world, driven by cost leadership, flexibility to manufacture multiple products in the same manufacturing facilities and capabilities in various therapeutic areas. Its API business has ensured the profitability and growth of its formulation business through seamless vertical integration. Its API business is supported by a technologically advanced R&D infrastructure that develops new products and plays a role in bringing products to market.

Two Aurobindo Pharma stock price targets for FY 2025. Aurobindo Pharma stock price in FY 2025 will be Rs 1050. And the second price target for Aurobindo Pharma for FY2025 will be around Rs 1100.

YearAurobindo Pharma Share Price Target 2025
First Target 2025Rs 1050
Second Target 2025Rs 1100

Also read:- Dalmia Bharat Share Price Target 2022, 2023, 2024, 2025, 2030

Aurobindo Pharma Share Price Target 2022, 2023, 2024, 2025, 2030

Aurobindo Pharma Share Price Target 2030

Eugia Pharma Specialties, a wholly owned subsidiary of Aurobindo Pharma, has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Medroxyprogesterone Acetate Suspension for Injection USP, 150 mg/mL, 1 mL single-dose vial. Medroxyprogesterone acetate injectable suspension USP, 150 mg/mL, 1 mL single-dose vial, intended to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Depo-Provera Injectable Suspension, by Pfizer Inc.

The target price of Aurobindo Pharma shares will be available by the end of financial year 2030. The price of the first share of Aurobindo Pharma will be Rs 2200. And the second price target of Aurobindo Pharma stock will be Rs 2300 by the end of the financial year 2030.

YearAurobindo Pharma Share Price Target 2030
First Target 2030Rs 2200
Second Target 2030Rs 2300

Also read:- Gland Pharma Share Price Target 2022, 2023, 2024, 2025, 2030

Future Prospectus of Aurobindo Pharma Share

  • Aurobindo Pharma plans to expand its renewable energy portfolio by acquiring existing projects and is also looking for new opportunities in the transmission and distribution sector.
  • Aurobindo Pharma plans to expand its renewable energy portfolio by acquiring existing projects and is also looking for new opportunities in the transmission and distribution sector.

Aurobindo Pharma Share Price Target 2022, 2023, 2024, 2025, 2030 Table

YearAurobindo Pharma Share Price Target
First Target 2022Rs 630
Second Target 2022Rs 650
First Target 2023Rs 750
Second Target 2023Rs 780
First Target 2024Rs 900
Second Target 2024Rs 930
First Target 2025Rs 1050
Second Target 2025Rs 1100
First Target 2030Rs 2200
Second Target 2030Rs 2300
Aurobindo Pharma Share Price Target 2022, 2023, 2024, 2025, 2030 Table

Risk of Aurobindo Pharma Share

  • Aurobindo Pharma needs additional funds to realize its full potential across the industry, otherwise Aurobindo Pharma will not be able to provide benefits or returns to its investors in the coming years.
  • Aurobindo Pharma Has a very high debt to the company which needs to be reduced in the coming years otherwise any sales or income they generate annually will be used to cover their debts.

Expert Views on Aurobindo Pharma Share

With all the features related to Aurobindo Pharma, we can say that you should watch this stock for some time and I would say you need to wait some time before investing in Aurobindo Pharma stock.

Aurobindo Pharma Share F.A.Q.

– Where is the headquarters of Aurobindo Pharma located?

AuroBindo Pharma Headquarters Located in Hyderabad, India.

– Who is the current MD of Aurobindo Pharma?

The current MD of Aurobindo Pharma is Nithyananda Reddy.

– What business is Aurobindo Pharma involved in?

Aurobindo Pharma is engaged in the manufacturing of pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations such as astemizole, domperidone and omeprazole; anti-infectives, oral and sterile antibiotics, pain management and osteoporosis segments.

 I hope that after reading the article Aurobindo Pharma Share Price Target 2022, 2023, 2024, 2025, 2030 you must have got a good idea what kind of performance can be seen in the growth of the Company. If you still have any question related to this article in your mind, then do not forget to tell in the comment at all. Stay tuned to Market in India for important information about this type of stock in the stock market.

Also read:-

Rate this post

Leave a Reply

Your email address will not be published. Required fields are marked *